JP2025519029A5 - - Google Patents
Info
- Publication number
- JP2025519029A5 JP2025519029A5 JP2024566284A JP2024566284A JP2025519029A5 JP 2025519029 A5 JP2025519029 A5 JP 2025519029A5 JP 2024566284 A JP2024566284 A JP 2024566284A JP 2024566284 A JP2024566284 A JP 2024566284A JP 2025519029 A5 JP2025519029 A5 JP 2025519029A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- pharmaceutically acceptable
- disease
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263364459P | 2022-05-10 | 2022-05-10 | |
| US63/364,459 | 2022-05-10 | ||
| PCT/US2023/021668 WO2023220131A2 (en) | 2022-05-10 | 2023-05-10 | PI3Kα INHIBITORS AND METHODS OF USE THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025519029A JP2025519029A (ja) | 2025-06-24 |
| JP2025519029A5 true JP2025519029A5 (cg-RX-API-DMAC10.html) | 2026-07-06 |
Family
ID=88730972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024566284A Pending JP2025519029A (ja) | 2022-05-10 | 2023-05-10 | PI3Kα阻害剤及びその使用方法 |
Country Status (14)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021263914B2 (en) | 2020-04-29 | 2026-07-23 | D.E. Shaw Research, Llc | PI3K-α inhibitors and methods of use thereof |
| EP4598919A1 (en) * | 2022-10-07 | 2025-08-13 | Scorpion Therapeutics, Inc. | Methods for treating cancer |
| WO2024199430A1 (zh) * | 2023-03-31 | 2024-10-03 | 长春金赛药业有限责任公司 | PI3Kα抑制剂化合物、药物组合物及其应用 |
| WO2024220876A1 (en) * | 2023-04-19 | 2024-10-24 | Alcon Inc. | N-substituted c6 cyclyl carboxamide compounds and uses thereof |
| WO2024233256A1 (en) | 2023-05-05 | 2024-11-14 | Eli Lilly And Company | Imlunestrant or salts thereof for use in treating and preventing central nervous system (cns) metastases in subjects having er+ breast cancer |
| KR20260113070A (ko) * | 2023-11-15 | 2026-07-21 | 릴레이 테라퓨틱스, 인크. | PI3Kα 저해제 그리고 이의 제조 방법 및 사용 방법 |
| WO2026041679A1 (en) * | 2024-08-22 | 2026-02-26 | F. Hoffmann-La Roche Ag | Pyridone carboxamide derived compounds as soluble epoxide hydrolase inhibitors |
| WO2026092678A1 (zh) * | 2024-11-01 | 2026-05-07 | 上海翰森生物医药科技有限公司 | 芳香胺类衍生物抑制剂、其制备方法和应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD145599A1 (de) * | 1979-08-23 | 1980-12-24 | Roswitha Toepfer | Mittel zur regulierung des pflanzenwachstums |
| CA2528938A1 (en) * | 2003-06-13 | 2005-02-24 | Zentaris Gmbh | Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
| PT1940839E (pt) * | 2005-10-07 | 2013-10-10 | Exelixis Inc | Inibidores de piridopirimidinona pi3k alfa |
| ZA200904857B (en) * | 2007-02-22 | 2010-09-29 | Merck Serono Sa | Quinoxaline compounds and use thereof |
| UA98141C2 (ru) * | 2007-04-11 | 2012-04-25 | Экселиксис, Инк. | Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа |
| EP2338888A1 (en) * | 2009-12-24 | 2011-06-29 | Almirall, S.A. | Imidazopyridine derivatives as JAK inhibitors |
| WO2012155199A1 (en) * | 2011-05-16 | 2012-11-22 | Bionomics Limited | Amine derivatives as potassium channel blockers |
| TWI574962B (zh) * | 2012-11-14 | 2017-03-21 | 加拓科學公司 | 作爲pi3激酶調節劑的芳雜環化合物及其使用方法和用途 |
| AU2014331049B2 (en) * | 2013-10-04 | 2018-03-29 | Torqur Ag | Conformationally restricted PI3K and mTOR inhibitors |
| CN105503877A (zh) * | 2014-09-24 | 2016-04-20 | 和记黄埔医药(上海)有限公司 | 咪唑并哒嗪类化合物及其用途 |
| AR105324A1 (es) * | 2015-07-17 | 2017-09-27 | Bayer Cropscience Ag | Hidrazidas de ácido carboxílico arilo y heteroarilo cíclicas sustituidas o sus sales y su uso para aumentar la tolerancia al estrés en plantas |
| MX2020000834A (es) * | 2017-08-02 | 2020-08-20 | Univ Tohoku | Derivado de adamantilmetilamina y uso del mismo como producto farmaceutico. |
| SG11202004361SA (en) * | 2017-11-13 | 2020-06-29 | Luoxin Pharmaceutical Shanghai Co Ltd | Quinazolinone compound and application thereof |
| CN108864074A (zh) * | 2018-06-20 | 2018-11-23 | 王延娇 | 一种化合物及其作为选择性pi3k抑制剂在治疗肿瘤中的应用 |
| ES3065954T3 (en) * | 2019-05-13 | 2026-05-08 | Relay Therapeutics Inc | Fgfr inhibitors and methods of use thereof |
| MX2022002282A (es) * | 2019-08-28 | 2022-03-25 | Unilever Ip Holdings B V | Compuestos novedosos para aclarar la piel. |
| AR121719A1 (es) * | 2020-04-03 | 2022-06-29 | Petra Pharma Corp | Inhibidores alostéricos de cromenona del fosfoinosítido 3-quinasa (pi3k) para el tratamiento de enfermedades |
| JP2023523402A (ja) * | 2020-04-29 | 2023-06-05 | イドーシア ファーマシューティカルズ リミテッド | スピロウレア誘導体 |
| AU2021263914B2 (en) * | 2020-04-29 | 2026-07-23 | D.E. Shaw Research, Llc | PI3K-α inhibitors and methods of use thereof |
| KR20230026404A (ko) * | 2020-06-17 | 2023-02-24 | 머크 샤프 앤드 돔 엘엘씨 | Nav1.8 억제제로서의 2-옥소-옥사졸리딘-5-카르복스아미드 |
| CN113045559B (zh) * | 2021-03-15 | 2022-05-20 | 贵州医科大学 | 一种二芳基脲类PI3Kα/mTOR双靶点抑制剂及其药物组合物和应用 |
| CA3217937A1 (en) * | 2021-05-03 | 2022-11-10 | Erin Danielle ANDERSON | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease |
| MX2023014819A (es) * | 2021-06-14 | 2024-03-21 | Scorpion Therapeutics Inc | Derivados de la urea que pueden ser utilizados para tratar el cancer. |
| EP4412606A4 (en) * | 2021-10-07 | 2025-09-24 | Relay Therapeutics Inc | PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF |
-
2023
- 2023-05-10 US US18/863,452 patent/US20250313524A1/en active Pending
- 2023-05-10 JP JP2024566284A patent/JP2025519029A/ja active Pending
- 2023-05-10 EP EP23804183.4A patent/EP4522583A4/en active Pending
- 2023-05-10 CN CN202380051476.5A patent/CN119486992A/zh active Pending
- 2023-05-10 KR KR1020247040801A patent/KR20250024871A/ko active Pending
- 2023-05-10 AR ARP230101150A patent/AR129281A1/es unknown
- 2023-05-10 CA CA3251244A patent/CA3251244A1/en active Pending
- 2023-05-10 WO PCT/US2023/021668 patent/WO2023220131A2/en not_active Ceased
- 2023-05-10 PE PE2024002478A patent/PE20251748A1/es unknown
- 2023-05-10 AU AU2023267583A patent/AU2023267583A1/en active Pending
- 2023-05-10 IL IL316619A patent/IL316619A/en unknown
- 2023-05-10 TW TW112117403A patent/TW202400175A/zh unknown
-
2024
- 2024-11-06 CL CL2024003398A patent/CL2024003398A1/es unknown
- 2024-11-07 MX MX2024013762A patent/MX2024013762A/es unknown
-
2025
- 2025-08-11 US US19/296,535 patent/US20260035335A1/en active Pending
- 2025-08-29 CL CL2025002635A patent/CL2025002635A1/es unknown